beta-Cyclocitral
CAS No. 432-25-7
beta-Cyclocitral( —— )
Catalog No. M21264 CAS No. 432-25-7
beta-Cyclocitral belongs to the class of organic compounds.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 5MG | 30 | In Stock |
|
| 10MG | 41 | In Stock |
|
| 25MG | 64 | In Stock |
|
| 50MG | 88 | In Stock |
|
| 100MG | 128 | In Stock |
|
| 200MG | 183 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namebeta-Cyclocitral
-
NoteResearch use only, not for human use.
-
Brief Descriptionbeta-Cyclocitral belongs to the class of organic compounds.
-
Descriptionbeta-Cyclocitral belongs to the class of organic compounds.
-
In Vitroβ-Cyclocitral is derived from the catalytic breakdown of β-carotene, and evidence indicates that it is produced by the activation of a specific carotene oxygenase by all species of the bloom-forming cyanobacterium Microcystis. β-cyclocitral affects grazer behavior.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number432-25-7
-
Formula Weight152.23
-
Molecular FormulaC10H16O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (656.86 mM)
-
SMILESCC1=C(C=O)C(C)(C)CCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Harada K I Ozaki K Tsuzuki S et al. Blue Color Formation of Cyanobacteria with β-Cyclocitral[J]. journal of chemical ecology 2009 35(11):1295-1301.
molnova catalog
related products
-
Cyclo(Ala-Tyr)
Cyclo(Val-Tyr) is a product from the culture of Pseudomonas putida.
-
Lateritin
Lateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
-
WKYMVM TFA
WKYMVm is a selective FPR2 agonist with high affinity, which was identified through screening of a synthetic peptide library.
Cart
sales@molnova.com